Catalyst Wire Dossier Catalyst Wire Dossier

Trivalent Inactivated Influenza Vaccine (Formulation 2012-2013)

trivalent inactivated influenza vaccine · Adimmune Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trivalent Inactivated Influenza Vaccine (Formulation 2012-2013), covering 2012-12-19 to 2012-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects [Phase 4]

See pricing